General Information of Drug Transporter (DT)
DT ID DTD0091 Transporter Info
Gene Name SLC13A1
Transporter Name Sodium/sulfate cotransporter 1
Gene ID
6561
UniProt ID
Q9BZW2
Epigenetic Regulations of This DT (EGR)

Methylation

  Pancretic ductal adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

5'UTR (cg05146599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.13E-02; Z-score: 5.58E-01

Methylation in Case

8.54E-01 (Median) Methylation in Control 8.14E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

3'UTR (cg00928751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 6.47E-07; Z-score: -1.40E+00

Methylation in Case

7.96E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in hepatocellular carcinoma [ 2 ]

Location

TSS1500 (cg03564727)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.40E+00 Statistic Test p-value: 2.27E-11; Z-score: -4.97E+00

Methylation in Case

5.90E-01 (Median) Methylation in Control 8.26E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in hepatocellular carcinoma [ 2 ]

Location

TSS200 (cg00895997)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 6.77E-06; Z-score: -1.79E+00

Methylation in Case

3.66E-01 (Median) Methylation in Control 4.85E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC13A1 in hepatocellular carcinoma [ 2 ]

Location

1stExon (cg22024657)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 9.76E-05; Z-score: -5.02E-01

Methylation in Case

7.43E-01 (Median) Methylation in Control 7.70E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC13A1 in hepatocellular carcinoma [ 2 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 1.81E-02; Z-score: -3.79E-01

Methylation in Case

1.15E-01 (Median) Methylation in Control 1.27E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Bladder cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in bladder cancer [ 3 ]

Location

TSS200 (cg00895997)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.57E+00 Statistic Test p-value: 3.71E-08; Z-score: -1.37E+01

Methylation in Case

4.35E-01 (Median) Methylation in Control 6.82E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in bladder cancer [ 3 ]

Location

1stExon (cg22024657)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 7.53E-04; Z-score: -6.48E+00

Methylation in Case

8.16E-01 (Median) Methylation in Control 8.97E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in lung adenocarcinoma [ 4 ]

Location

TSS200 (cg00895997)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 3.07E-02; Z-score: -2.19E+00

Methylation in Case

7.09E-01 (Median) Methylation in Control 7.64E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in lung adenocarcinoma [ 4 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 1.55E-04; Z-score: 3.42E+00

Methylation in Case

1.73E-01 (Median) Methylation in Control 1.30E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in papillary thyroid cancer [ 5 ]

Location

TSS200 (cg00895997)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.59E-03; Z-score: -9.08E-01

Methylation in Case

7.89E-01 (Median) Methylation in Control 8.23E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in papillary thyroid cancer [ 5 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 1.77E-07; Z-score: -1.27E+00

Methylation in Case

1.23E-01 (Median) Methylation in Control 1.52E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in systemic lupus erythematosus [ 6 ]

Location

TSS200 (cg00895997)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.67E-02; Z-score: -2.14E-01

Methylation in Case

7.57E-01 (Median) Methylation in Control 7.74E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in atypical teratoid rhabdoid tumor [ 7 ]

Location

1stExon (cg22024657)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.30E+00 Statistic Test p-value: 8.58E-17; Z-score: -2.52E+00

Methylation in Case

6.88E-01 (Median) Methylation in Control 8.92E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in atypical teratoid rhabdoid tumor [ 7 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 5.15E-04; Z-score: -7.25E-01

Methylation in Case

9.42E-01 (Median) Methylation in Control 9.55E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Breast cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in breast cancer [ 8 ]

Location

1stExon (cg22024657)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 9.14E-05; Z-score: -1.10E+00

Methylation in Case

8.25E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC13A1 in breast cancer [ 8 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 5.08E-08; Z-score: 1.96E+00

Methylation in Case

1.16E-01 (Median) Methylation in Control 8.17E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  HIV infection

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in HIV infection [ 9 ]

Location

Body (cg03993154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.46E+00 Statistic Test p-value: 1.59E-06; Z-score: 2.27E+00

Methylation in Case

1.96E-01 (Median) Methylation in Control 1.34E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Prostate cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC13A1 in prostate cancer [ 10 ]

Location

Body (cg14084826)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 4.97E-02; Z-score: -3.85E+00

Methylation in Case

5.91E-01 (Median) Methylation in Control 7.98E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples
References
1 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
3 DNA Methylation Dynamics in Urological Tumors.
4 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
5 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
6 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
7 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
8 Genome-wide Scan for Methylation Profiles in Breast Cancer
9 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
10 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.